Acrylamide compounds as histamine h3 receptor ligands
The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | NIROGI RAMAKRISHNA SHINDE ANIL KARBHARI DWARAMPUDI ADI REDDY JASTI VENKATESWARLU |
description | The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ703323A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ703323A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ703323A3</originalsourceid><addsrcrecordid>eNrjZDB1TC6qzEnMzUxJVUjOzy3IL81LKVZILFbIyCwuAQrnpSpkGCsUpSanFpTkFynkZKYnAhXwMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JJ4vyhzA2NjI2NHY4IKAGkzLBI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Acrylamide compounds as histamine h3 receptor ligands</title><source>esp@cenet</source><creator>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</creator><creatorcontrib>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</creatorcontrib><description>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160331&DB=EPODOC&CC=NZ&NR=703323A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160331&DB=EPODOC&CC=NZ&NR=703323A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIROGI RAMAKRISHNA</creatorcontrib><creatorcontrib>SHINDE ANIL KARBHARI</creatorcontrib><creatorcontrib>DWARAMPUDI ADI REDDY</creatorcontrib><creatorcontrib>JASTI VENKATESWARLU</creatorcontrib><title>Acrylamide compounds as histamine h3 receptor ligands</title><description>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1TC6qzEnMzUxJVUjOzy3IL81LKVZILFbIyCwuAQrnpSpkGCsUpSanFpTkFynkZKYnAhXwMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JJ4vyhzA2NjI2NHY4IKAGkzLBI</recordid><startdate>20160331</startdate><enddate>20160331</enddate><creator>NIROGI RAMAKRISHNA</creator><creator>SHINDE ANIL KARBHARI</creator><creator>DWARAMPUDI ADI REDDY</creator><creator>JASTI VENKATESWARLU</creator><scope>EVB</scope></search><sort><creationdate>20160331</creationdate><title>Acrylamide compounds as histamine h3 receptor ligands</title><author>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ703323A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NIROGI RAMAKRISHNA</creatorcontrib><creatorcontrib>SHINDE ANIL KARBHARI</creatorcontrib><creatorcontrib>DWARAMPUDI ADI REDDY</creatorcontrib><creatorcontrib>JASTI VENKATESWARLU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIROGI RAMAKRISHNA</au><au>SHINDE ANIL KARBHARI</au><au>DWARAMPUDI ADI REDDY</au><au>JASTI VENKATESWARLU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Acrylamide compounds as histamine h3 receptor ligands</title><date>2016-03-31</date><risdate>2016</risdate><abstract>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ703323A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Acrylamide compounds as histamine h3 receptor ligands |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T07%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIROGI%20RAMAKRISHNA&rft.date=2016-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ703323A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |